RBC Capital Markets

Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement

Retrieved on: 
Thursday, March 7, 2024
Research, Mental Health, Neurology, Clinical Trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, Janus, Attention, Prospectus, Medicine, Capital market, MindMed, Telephone, RBC Capital Markets, File, Cantor, Sale, Form, Richard Driehaus, State Street, SVB Securities, Security (finance)

In addition, the Company has entered into share purchase agreements for a concurrent private placement of 12,500,000 common shares at a price of $6.00 per common share.

Key Points: 
  • In addition, the Company has entered into share purchase agreements for a concurrent private placement of 12,500,000 common shares at a price of $6.00 per common share.
  • Gross proceeds to MindMed from the underwritten offering and concurrent private placement, before deducting underwriting commissions, placement agent fees and other offering-related expenses, are expected to be approximately $175 million.
  • Leerink Partners and Cantor are acting as joint bookrunning managers for the underwritten offering and placement agents for the private placement.
  • RBC Capital Markets is acting as lead manager for the underwritten offering and placement agent for the private placement.

Argonaut Manufacturing Services Expands Aseptic Pharmaceutical Fill / Finish Capabilities with $45 Million Equity Investment from NewVale Capital and Telegraph Hill Partners

Retrieved on: 
Tuesday, March 5, 2024
Packaging, Health, Manufacturing, Other Manufacturing, Pharmaceutical, Biotechnology, ISO, FDA, RBC Capital Markets, Syringe, CFR, Peptide, PMDA, Certification, Patient, Protein, Oligonucleotide

Argonaut Manufacturing Services (“Argonaut”), a leading contract development and manufacturing organization serving the biopharma and life sciences industries, announced today the completion of a $45 million financing to support its new drug product fill / finish expansion.

Key Points: 
  • Argonaut Manufacturing Services (“Argonaut”), a leading contract development and manufacturing organization serving the biopharma and life sciences industries, announced today the completion of a $45 million financing to support its new drug product fill / finish expansion.
  • Argonaut expects to have fully validated the facility and all equipment in 2025.
  • The financing was led by NewVale Capital, a growth equity fund focused on innovative pharmaceutical and life science services businesses, with participation from existing majority investor Telegraph Hill Partners, and other current investors.
  • “For years, small- and medium-sized biopharma companies have struggled to find reliable, high-quality fill / finish capabilities from providers that prioritize their molecules.

Rambus Initiates Accelerated Share Repurchase Program

Retrieved on: 
Friday, March 1, 2024
Networks, Semiconductor, Hardware, Data Management, Technology, Share repurchase, Royal Bank of Canada, RBC Capital Markets, Growth, RMBS, Inc., Silicon

Rambus Inc. (NASDAQ: RMBS ), a premier chip and silicon IP provider making data faster and safer, today announced that it initiated an accelerated share repurchase program with Royal Bank of Canada, through its agent RBC Capital Markets, LLC (“Dealer”) to repurchase an aggregate of approximately $50 million of its common stock.

Key Points: 
  • Rambus Inc. (NASDAQ: RMBS ), a premier chip and silicon IP provider making data faster and safer, today announced that it initiated an accelerated share repurchase program with Royal Bank of Canada, through its agent RBC Capital Markets, LLC (“Dealer”) to repurchase an aggregate of approximately $50 million of its common stock.
  • “As part of our ongoing capital allocation strategy and commitment to increasing stockholder value, this share repurchase program reflects the strength of our balance sheet and cash generation, and demonstrates our continued confidence in the long-term growth of the company,” said Luc Seraphin, president and chief executive officer at Rambus.
  • Under the accelerated share repurchase program, Rambus will pre-pay $50 million to Dealer and receive an initial delivery of approximately 675,000 shares of its common stock within the first week of the program.
  • The accelerated share repurchase program is part of the broader share repurchase program previously authorized by the Rambus Board of Directors.

J.D. Power Sets Sights on European Expansion with Completion of Autovista Group Acquisition

Retrieved on: 
Friday, March 1, 2024
Technology, Marketing, Consulting, Communications, Other Consumer, Professional Services, Other Transport, Artificial Intelligence, General Automotive, Transport, Aftermarket, Automotive, Software, Consumer, Data Analytics, Acquisition, EV, J.D. Power, Kirkland & Ellis, Forecasting, AI, RBC Capital Markets, Cravath, Swaine & Moore

Power, a global leader in data analytics, today announced the completion of its acquisition of Autovista Group, a leading pan-European and Australian automotive data, analytics and industry insights provider.

Key Points: 
  • Power, a global leader in data analytics, today announced the completion of its acquisition of Autovista Group, a leading pan-European and Australian automotive data, analytics and industry insights provider.
  • The acquisition, which was announced in September 2023, brings together Autovista Group’s comprehensive datasets, insights and industry expertise with J.D.
  • Autovista Group was previously owned by Hayfin Capital Management, a leading European alternative asset management firm.
  • TD Cowen served as exclusive financial advisor and Macfarlanes, Cravath, Swaine & Moore and Mishcon de Reya served as legal advisors to Autovista Group and Hayfin.

Sixth Street Specialty Lending, Inc. Prices Public Offering of Common Stock

Retrieved on: 
Friday, March 1, 2024
Professional Services, Finance, Varick Street, Prospectus, Investment, J. P. Morgan, RBC Capital Markets, 2nd Floor, Sale, Wells Fargo, Morgan Stanley, Keefe, Bruyette & Woods, BofA Securities, Security (finance), Goldman Sachs, Citigroup

Sixth Street Specialty Lending, Inc. (NYSE:TSLX) (“TSLX” or the “Company”) announced today that it has priced a public offering of 4,000,000 shares of its common stock for total gross proceeds of approximately $83.4 million.

Key Points: 
  • Sixth Street Specialty Lending, Inc. (NYSE:TSLX) (“TSLX” or the “Company”) announced today that it has priced a public offering of 4,000,000 shares of its common stock for total gross proceeds of approximately $83.4 million.
  • In connection with the offering, the Company has granted the underwriters for the offering an option to purchase up to an additional 600,000 shares of its common stock.
  • The offering is subject to customary closing conditions, and the shares are expected to be delivered on or about March 5, 2024.
  • TSLX expects to use the net proceeds of the offering to pay down outstanding debt under its revolving credit facility.

Sixth Street Specialty Lending, Inc. Announces Public Offering of Common Stock

Retrieved on: 
Thursday, February 29, 2024
Professional Services, Business, Finance, Varick Street, Prospectus, Investment, J. P. Morgan, RBC Capital Markets, File, 2nd Floor, Sale, Wells Fargo, Morgan Stanley, Keefe, Bruyette & Woods, BofA Securities, Security (finance), Goldman Sachs, Citigroup

Sixth Street Specialty Lending, Inc. (NYSE:TSLX) (“TSLX” or the “Company”) announced today that it has launched a public offering of 4,000,000 shares of its common stock.

Key Points: 
  • Sixth Street Specialty Lending, Inc. (NYSE:TSLX) (“TSLX” or the “Company”) announced today that it has launched a public offering of 4,000,000 shares of its common stock.
  • TSLX also plans to grant the underwriters for the offering an option to purchase up to an additional 600,000 shares of its common stock.
  • The offering will be made pursuant to a registration statement, which has been filed with the Securities and Exchange Commission (the “SEC”) and became effective automatically upon filing.
  • TSLX expects to use the net proceeds of the offering to pay down outstanding debt under its revolving credit facility.

Healthpeak Properties Closes Merger with Physicians Realty Trust

Retrieved on: 
Friday, March 1, 2024
Residential Building & Real Estate, Construction & Property, REIT, Morgan Stanley, J.P. Morgan & Co., Trustee, Property, RBC Capital Markets, PEAK, New York Stock Exchange, Wells Fargo, BofA Securities, Latham & Watkins, Barclays, Financial adviser

Healthpeak Properties, Inc. (NYSE: PEAK) (“Healthpeak”) today announced that it has closed on the previously announced merger with Physicians Realty Trust.

Key Points: 
  • Healthpeak Properties, Inc. (NYSE: PEAK) (“Healthpeak”) today announced that it has closed on the previously announced merger with Physicians Realty Trust.
  • “We are pleased to announce the completion of our merger with Physicians Realty Trust,” said Scott Brinker, President and Chief Executive Officer of Healthpeak.
  • Proceeds from the term loan were used toward the repayment of $210 million of Physicians Realty Trust private placement notes and will be used for general corporate purposes, including transaction costs and repayment of borrowings under Healthpeak's commercial paper program.
  • BofA Securities and KeyBanc Capital Markets Inc. acted as lead financial advisors, BMO Capital Markets Corp. served as financial advisor, and Baker McKenzie acted as legal advisor to Physicians Realty Trust.

Radian Prices Senior Notes Offering

Retrieved on: 
Thursday, February 29, 2024
Residential Building & Real Estate, Construction & Property, Professional Services, Insurance, Prospectus, Capital market, RDN, Note, Telephone, RBC Capital Markets, UBS, Sale, Form, RBC, Security (finance), Goldman Sachs, CIBC, Hand, Offering

Radian Group Inc. (NYSE: RDN) announced today that it has priced its public offering (the “Offering”) of $625 million aggregate principal amount of senior unsecured notes due 2029 (the “Notes”).

Key Points: 
  • Radian Group Inc. (NYSE: RDN) announced today that it has priced its public offering (the “Offering”) of $625 million aggregate principal amount of senior unsecured notes due 2029 (the “Notes”).
  • The Offering is expected to close on March 4, 2024, subject to customary closing conditions.
  • The Company intends to use the net proceeds from the Offering to redeem the Company’s 6.625% senior notes due March 2025.
  • The Offering may be made only by means of a prospectus supplement and accompanying base prospectus filed with the SEC.

Popular, Inc. to Participate in the RBC Capital Markets 2024 Financial Institutions Conference

Retrieved on: 
Tuesday, February 27, 2024
Banking, Professional Services, Finance, RBC Capital Markets, Popular, Inc., BPOP, Webcast, Conference

Popular, Inc. (NASDAQ: BPOP) announced today that it will participate in the upcoming RBC Capital Markets Financial Institutions Conference to be held in New York City on Tuesday March 5, 2024.

Key Points: 
  • Popular, Inc. (NASDAQ: BPOP) announced today that it will participate in the upcoming RBC Capital Markets Financial Institutions Conference to be held in New York City on Tuesday March 5, 2024.
  • Carlos J. Vázquez, Executive Vice President and Chief Financial Officer of Popular, Inc., will speak at 4:00 p.m. Eastern Time.
  • A live audio webcast will be accessible through the Popular, Inc. Investor Relations website at https://investor.popular.com/eng/investor-relations/default.aspx .
  • A replay of the webcast will also be available.

Fifth Third Bancorp to Participate in the RBC Capital Markets Financial Institutions Conference

Retrieved on: 
Thursday, February 22, 2024
Banking, Professional Services, Finance, RBC Capital Markets, FITB, Fifth Third Bank, Conference

Fifth Third Bancorp (Nasdaq: FITB) will participate in the 2024 RBC Capital Markets Financial Institutions Conference on March 6, 2024, at approximately 8:00 AM ET.

Key Points: 
  • Fifth Third Bancorp (Nasdaq: FITB) will participate in the 2024 RBC Capital Markets Financial Institutions Conference on March 6, 2024, at approximately 8:00 AM ET.
  • Tim Spence, chairman, chief executive officer and president, and Bryan Preston, executive vice president and chief financial officer, will represent the Company.
  • Audio webcast and any presentation slides may be viewed live and for approximately 14 days after the conference through the Investor Relations section of www.53.com .
  • Additionally, any slides used in the presentation will be made available in a printer-friendly format on the Company’s website.